Top hospitals more likely to use stents and clot-inhibiting drugs in angioplasty. [electronic resource]
- Report on medical guidelines & outcomes research Aug 2000
- 8-9 p. digital
Publication Type: Comparative Study; News
1050-5636
Angioplasty, Balloon, Coronary--economics Anticoagulants--economics Benchmarking Fibrinolytic Agents--economics Hospitals Humans Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors Stents--economics United States